Guideline Committee
This Committee will be drawn from the Panel that has shepherded the development of the Guideline to ensure continuity during the launch phase and will transition in 2023 to a broader membership.
Research Committee
To develop a forward-thinking research strategy for AADPA based on need, leveraging the Guidelines, opportunities for next-generation researchers and opportunities to lead or partner on grants.
Finance & Audit Committee
A new Director will lead this Committee that will develop a strategy for AADPA to have better funding and revenue certainty. It will also be responsible for overseeing the organisation’s reporting requirements.
Education & Training Committee
To develop and consider initiatives that will advance professional development for members, consider micro-credentialing revenue pathways and other fee-paying training programs. Also includes forging relationships with academic institutions that could develop curricula to train the next generation of clinicians better.
Advocacy Panel
This Panel will work on initiatives that promote better policy, such as a national standardised guideline for prescribing stimulant medication and models of care. It will also include partnering with consumer and community groups on campaigns and programs to advance better understanding and acceptance of ADHD.
